Nature 2007 Meredith. Wadman - Abstracts

Nature 2007 Meredith. Wadman
TitleSubjectAuthors
A merger too far?(Bristol-Myers Squibb Co. and Sanofi-Aventis S.A.)Zoology and wildlife conservationMeredith Wadman
Anaemic outlook for Amgen.(Amgen Biologicals/Diagnostics)Zoology and wildlife conservationMeredith Wadman
Autism speaks: the United States pays up.Zoology and wildlife conservationMeredith Wadman
Bush and Congress set debate on priorities.Zoology and wildlife conservationMeredith Wadman, Geoff Brumfiel, Lucy Odling-Smee, Emma Marris
Congress and Bush set to clash on stem cells again.Zoology and wildlife conservationMeredith Wadman
Copycat consolidation.(selling of cheaper copies of generic drugs)Zoology and wildlife conservationMeredith Wadman
Dolly: A decade on.(debate on mammalian cloning)Zoology and wildlife conservationMeredith Wadman
Genome miners rush to stake claims.Zoology and wildlife conservationMeredith Wadman
Man on a mission.(diabetes drug Avandia)Zoology and wildlife conservationMeredith Wadman
Meeting in the middle.(biotechnology drugs)Zoology and wildlife conservationMeredith Wadman
Merck settles Vioxx lawsuits for $4.85 billion.(Merck compensates for its drug with side effects)Zoology and wildlife conservationMeredith Wadman
Moment of reckoning.(new laws for the regulation of the drug industry)Zoology and wildlife conservationMeredith Wadman
Patent crunch pending.(Patent Reform Act of 2007)Zoology and wildlife conservationMeredith Wadman
Regulator under siege.(inquiry of FDA agency in Maryland)Zoology and wildlife conservationMeredith Wadman
State of the donation.(biomedical research funding from private foundations and philanthropy)Zoology and wildlife conservationMeredith Wadman
Stem-cell issue moves up the US agenda.(Stem Cell Research Enhancement Act of 2007)Zoology and wildlife conservationMeredith Wadman
The map man.(Alan Krensky of Office of Portfolio Analysis and Strategic Initiatives)(Occupation overview)Zoology and wildlife conservationMeredith Wadman
The pain game.(Food and Drug Administration bans Arcoxia and Vioxx)Zoology and wildlife conservationMeredith Wadman
When the party's over.(Pfizer Inc.'s new strategy after failure of cholesterol-lowering drug torcetrapib)Zoology and wildlife conservationMeredith Wadman
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.